Diabetic Complications Global Clinical Trials Review, H2, 2017

2017-07-26
Price :
Published : Jul-2017
No. of Pages : 1098

Diabetic Complications Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Diabetic Complications Global Clinical Trials Review, H2, 2017” provides an overview of Diabetic Complications clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Complications. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in November 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the re......
$1000

Malignant Mesothelioma Global Clinical Trials Review, H2, 2017

Malignant Mesothelioma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Malignant Mesothelioma Global Clinical Trials Review, H2, 2017" provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Mesothelioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma e......
$2500

Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017

Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Metastatic Uveal Melanoma Global Clinical Trials Review, H2, 2017" provides an overview of Metastatic Uveal Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Metastatic Uveal Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Melanoma Global Clinical Trials Review, H2, 2017

Melanoma Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Melanoma Global Clinical Trials Review, H2, 2017" provides an overview of Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are coll......
$2500

Mixed Dyslipidemia Global Clinical Trials Review, H2, 2017

Mixed Dyslipidemia Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Mixed Dyslipidemia Global Clinical Trials Review, H2, 2017" provides an overview of Mixed Dyslipidemia clinical trials scenario. This report provides top line data relating to the clinical trials on Mixed Dyslipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical t......
$2500

Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2017

Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Metachromatic Leukodystrophy (MLD) Global Clinical Trials Review, H2, 2017" provides an overview of Metachromatic Leukodystrophy (MLD) clinical trials scenario. This report provides top line data relating to the clinical trials on Metachromatic Leukodystrophy (MLD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated us......
$2500

Malignant Pleural Effusion Global Clinical Trials Review, H2, 2017

Malignant Pleural Effusion Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Malignant Pleural Effusion Global Clinical Trials Review, H2, 2017" provides an overview of Malignant Pleural Effusion clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Pleural Effusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary dat......
$2500

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2017

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Global Clinical Trials Review, H2, 2017" provides an overview of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs fo......
$2500

Melasma (Chlosma) Global Clinical Trials Review, H2, 2017

Melasma (Chlosma) Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Melasma (Chlosma) Global Clinical Trials Review, H2, 2017" provides an overview of Melasma (Chlosma) clinical trials scenario. This report provides top line data relating to the clinical trials on Melasma (Chlosma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2017

Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, "Muckle-Wells Syndrome Global Clinical Trials Review, H2, 2017" provides an overview of Muckle-Wells Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Muckle-Wells Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500